Treatment of palmar hyperhidrosis with botulinum toxin type A: 44 months of experience

Authors: Pérez-Bernal, Ana María; Avalos-Peralta, Patricia; Moreno-Ramírez, David; Camacho, Francisco

Source: Journal of Cosmetic Dermatology, Volume 4, Number 3, September 2005 , pp. 163-166(4)

Buy & download fulltext article:

Price: $48.00 plus tax (Refund Policy)

Abstract:

Summary Background

Palmar hyperhidrosis (PH) can produce social and occupational difficulties and reduce the quality of life of those who suffer from this kind of problem. When dealing with focal hyperhidrosis, the patients’ attitudes and their subjective approaches regarding the process may influence the objective evaluation of the disorder. Objective

To evaluate, by means of a scale, the subjective improvement of sweat production after treatment with botulinum toxin type A (BTX-A) in a group of patients with severe, invalidating PH. Patients and methods

Over a period of 44 months, 69 patients were treated and followed-up, 27 patients had to be treated twice, and 11 patients required a third application; 80–100 U was injected in each palm. Regional nerve block was performed before the procedure. The patients were asked to evaluate their improvement at 1, 3, 6, 9, and 12 months of baseline. Results

At 1 month, 53.6% of the patients reported an excellent improvement. Three months later, results were still excellent in 33.3% of the patients, and acceptable in 29%. From then on there was a statistically significant decrease of BTX-A effectiveness. A second application was carried out at an interval of 7.5 ± 2.6 months, and a third one at 9 ± 4.4 months. The following complications could be observed: transitory weakness of hand muscles in 13 patients, wrist pain in 5 patients, and cramps in 1 patient. Conclusions

Botulinum toxin is an effective alternative for the treatment of severe, invalidating PH. The maximum improvement persists up to 3 months; from then on, the effects slowly diminish. In our experience, there were no statistically significant differences with further applications of BTX-A. The patients’ subjective assessment can be used to evaluate the sweat production after treatment with BTX-A in those medical centers where a more objective evaluation becomes difficult or impossible.

Keywords: botulinum toxin type A; palmar hyperhidrosis

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1473-2165.2005.00304.x

Affiliations: 1: Department of Dermatology, Hospital Virgen Macarena, Seville, Spain

Publication date: 2005-09-01

Treatment of palmar hyperhidrosis with botulinum toxin type A: 44 months of experience

Buy & download fulltext article:

Tools

Key

Text size:

Useful pages